Kite Announces New ZUMA-1 Cohort Analysis Evaluating Prophylactic Corticosteroid Use With Yescarta® in Patients With Relapsed or Refractory Large B-cell lymphoma Biotech Investing
Jamieson Wellness Inc. Announces Date of Fourth Quarter and Full Year 2020 Financial Results and Conference Call Pharmaceutical Investing
AbbVie and Caribou Biosciences Announce Collaboration and License Agreement for CAR-T Cell Products Biotech Investing
BOTOX® Receives FDA Approval for Pediatric Detrusor Overactivity Associated with a Neurologic Condition Biotech Investing
The Future of Mental Health and Addiction Therapy: Why Capital is Flowing into Psychedelics Psychedelics Investing
NYSE: BMY Shareholder Alert: Update in Lawsuit against Bristol-Myers Squibb Co announced by Shareholders Foundation Biotech Investing
Nextech AR's Virtual Event Platform Selected by Canadian Surgery Forum for Its 2021 Virtual Trade Show Medical Device Investing
Adjuvant Treatment with Opdivo Demonstrates Statistically Significant and Clinically Meaningful Improvement in Disease-Free Survival in Patients with Muscle-Invasive Urothelial Carcinoma in Phase 3 CheckMate -274 Trial Biotech Investing
OPDIVO® in Combination with CABOMETYX® Shows Sustained Survival and Response Rate Benefits as First-Line Treatment for Patients with Advanced Renal Cell Carcinoma in the Phase 3 CheckMate -9ER Trial Biotech Investing
